Optical biosensors for real-time measurement of analytes in blood plasma

https://doi.org/10.1016/S0956-5663(02)00028-3Get rights and content

Abstract

The preparation of assemblies consisting of multiple molecular layers of bovine serum albumin (BSA), monoclonal antibodies against horseradish peroxidase (anti-HRP), and monoclonal antibodies against methotrexate (anti-MTT), as well as interaction of the assemblies with human blood plasma were observed using a grating coupler and Young interferometer (YI). The assemblies could be arranged according to decreasing amounts of nonspecific deposits bound irreversibly to them from blood plasma as follows-an adsorbed antibody monolayer saturated with adsorbed BSA, antibody multilayers linked with polycations, antibodies covalently immobilized on a BSA layer densely crosslinked with glutaraldehyde (GA), slightly crosslinked BSA double layer, slightly crosslinked antibody double layers. The occurrence of human serum albumin (HSA), human fibrinogen (Fg), IgG, and IgM in the plasma deposits was studied by binding the respective antibodies. IgG, IgM, and Fg were detected in plasma deposits on the immobilized assemblies while the composition of a plasma deposit on the unmodified sensor surface reflected roughly the plasma composition containing mainly adsorbed HSA and Fg. A crosslinked anti-HRP double layer was immobilized on a waveguiding branch of YI and a similar anti-MTT double layer was immobilized on the other branch. The sensor response to blood plasma was fairly decreased owing to a compensation of the respective optical changes in the two branches, in which a similar non-specific adsorption took place. The addition of HRP or MTT to plasma induced specific responses of the corresponding branches.

Introduction

Within the last decade, biosensors based on interaction of evanescent waves at surfaces of various optical transducers with an analyzed medium have been developed (Lukosz, 1992). The affinity binding of molecular analytes from the tested medium to specific bioreceptors immobilized on the transducer surface induces detectable changes in the transducer optics. In contrast to immunoassays currently used in practice, biosensors are capable of direct real-time sensing without additional reagents (Lundström, 1994). Thus, the sensors could be unique when a fast analysis or the permanent in situ monitoring of analyte concentrations are required. On the other hand, unlike the methods based on labeled reagents, the direct sensor detection is not able to differentiate between a sensor response caused by the binding of analytes to specific receptors and a non-specific response caused by binding other compounds from tested media to the sensor surface. The non-specific response is particularly troublesome when measurements are performed in complex biological fluids, such as blood serum, blood plasma or whole blood. Plasma proteins adsorb on solid surfaces immediately after the contact with these body fluids. The adsorption is a complex and dynamic process in which proteins can change their tertiary structure and more strongly adsorbing proteins can subsequently replace proteins adsorbed first (Scott, 1991). In addition to simple physical adsorption at the solid liquid interface, a sequence of specific processes associated with activation of the coagulation and complement systems, such as binding, activation, and release of proteins and other blood components, occurs at any surface other than that of undamaged vascular wall endothelium (Coleman et al., 1994). So far, the non-specific interaction has been a substantial barrier for sensor applications in medical diagnostics.

There have been only few scientific papers describing real-time optical sensing in serum or plasma performed in a non-competitive way, i.e. without addition of reagents to the tested fluid (Anderson et al., 1998, Ravanat et al., 1998, Otamiri and Nilsson, 1999). The detection is possible only if the response to an analyte is high enough in comparison with the non-specific adsorption. The specific response is proportional to a mass added onto the sensor surface due to the analyte binding. Thus, the concentration and molecular weight of the analyte as well as its affinity to the immobilized receptors should be high, which is not common in practice. To prevent protein adsorption on the optical transducer, its surface was coated with hydrogels, such as (carboxymethyl)dextran (Löfäs and Johnsson, 1990) or poly(ethylene glycol) (Mrksich and Whitesides, 1997), so as the access of plasma proteins to the bare surface could be prevented, and bioreceptor molecules were attached covalently to the hydrogel. In a similar way, non-specific adsorption has been decreased several times when, instead of immobilizing a receptor monolayer directly on the transducer surface, the surface was coated with a crosslinked multilayer of the antibodies. (Brynda et al., 1998). Even if direct adsorption on the transducer surface is suppressed, there is usually another non-specific sensor response due to the binding of some plasma components to the hydrogel and immobilized bioreceptors. It is believed that some non-specific response is associated with the activation of complement by immobilized antibody receptors. A smaller deposit of human serum was observed on a sensor coated with a (carboxymethyl)dextran matrix on which chicken antibodies were immobilized instead of the commonly used mouse antibodies (Vikinge et al., 1998). The observed lower adsorption of complement activating factors C1q and C3 was assumed to reduce complement activation.

The aim of this work was to gain knowledge on the interaction between blood plasma and optical sensors which use immobilized monoclonal antibodies as bioreceptors and to minimize the non-specific sensor response so that sensors capable of measuring analytes in blood plasma could be designed. Two ways were combined to reach the goal: (i) The non-specific adsorption was suppressed by immobilization of multilayer assemblies of monoclonal antibodies on sensor surfaces and (ii) The non-specific optical response of the interferometer surface coated with antibodies sensitive to an analyte was compensated by a response from a reference interferometer surface coated with an antibody insensitive to the analyte.

Section snippets

Materials

Mouse monoclonal antibody against methotrexate (anti-MTT), mouse monoclonal antibody against horseradish peroxidase (anti-HRP), mouse monoclonal antibody against human immunoglobulin G (anti-IgG), mouse monoclonal antibody against human immunoglobulin M (anti-IgM), and mouse monoclonal antibody against human serum albumin (anti-HSA) were from Seva Imuno Praha, Prague. Bovine serum albumin (BSA), 99% by agarose electrophoresis, globulin free, (BSA), sodium dextran sulfate prepared from dextran

Protein assemblies on grating coupler chips

Anti-MTT and anti-HRP could be adsorbed on the Ta2O5 surface both from PBS above their isoelectric points at pH 7.4 and from CB below their isoelectric points at pH 4. The adsorption from CB was about 25% higher than from PBS. When CB was replaced with PBS, an excessive part of the antibody layer desorbed. Probably, some of the antibodies adsorbed from CB were attached to negatively charged sites on Ta2O5 by electrostatic interaction, while the rest of the layer, stable in PBS, was adsorbed

Conclusions

The binding of compounds from blood plasma was considerably suppressed when solid surfaces were coated with the assemblies containing BSA and mouse monoclonal antibodies. Multilayer coatings were much more effective than an adsorbed monolayer. The least binding of plasma compounds was observed with crosslinked double layers of monoclonal antibodies.

The presence of polycations in antibody multilayers and a dense GA crosslinking of the BSA layer increased the adsorption of plasma components.

Acknowledgements

The research was supported by the Grant Agency of the Czech Republic (grant 102/99/0549), the Grant Agency of the Academy of Sciences of the Czech Republic (grant A4050006/00).

References (19)

There are more references available in the full text version of this article.

Cited by (49)

  • Surface acoustic waves in biosensing applications

    2021, Sensors and Actuators Reports
    Citation Excerpt :

    It appears that label-free biosensors are superior to labeled detection schemes although they do have one inherent drawback. Label-free detection schemes are not able to differentiate between a sensor response caused by the binding of analytes to specific receptors and responses caused by nonspecific material binding to the sensor surface [177]. Currently, most reported sensing systems rely on a buffer solution containing an isolated antigen of interest to circumvent this problem.

  • Interferometry-based immunoassays

    2018, Handbook of Immunoassay Technologies: Approaches, Performances, and Applications
  • Catalyst-free “click” functionalization of polymer brushes preserves antifouling properties enabling detection in blood plasma

    2017, Analytica Chimica Acta
    Citation Excerpt :

    Moreover, the ease of parallelization of measurements contributes to the high throughput. Remarkably, assay times are minimized, as the samples need minimal processing and the output can typically be obtained in real time [8]. The rapid and parallel quantification of a multiple biomarkers can provide information about the underlying pathophysiological processes leading to disease states [9].

  • Point-of-Need bioanalytics based on planar optical interferometry

    2016, Biotechnology Advances
    Citation Excerpt :

    Even if one considers that the actual LOD would be 3 times the noise level, still this would correspond to a LOD of ΔΝeff,min = 1.5 × 19− 8 RIU, one of the best-recorded values so far. Feasibility studies for real-life clinical settings were also performed later, with YIs being employed for detection of antibodies in blood plasma (Brynda et al., 2002) with Si3N4/SiO2-based YIs on Si chips (Brandenburg et al., 2000) and tuberculosis-specific antibodies in human blood serum (Nagel et al., 2008) with commercial Ta2O5-YIs on glass (Unaxis Balzers, Liechtenstein) providing results at clinically relevant values. During the same period of time, a Ta2O5-waveguide on glass YI chip was used by the same group (Hoffmann et al., 2007).

  • Integrated planar optical waveguide interferometer biosensors: A comparative review

    2014, Biosensors and Bioelectronics
    Citation Excerpt :

    Testing its capabilities also in affinity binding measurements they revealed a detection limit of 9×10−8 and 0.75 pg/mm2 (Brandenburg et al., 2000). The viability of the sensor configuration for measurement of analytes in blood plasma, monitoring of protein production as well as clinical diagnostics was also demonstrated (Brynda et al., 2002; Hoffmann et al., 2007; Nagel et al., 2008). Schmitt et al. (2005) have published a remarkable configuration for biosensing in 2005.

  • Low cost, rapid fabrication of durable molds of grating arrays for nanoimprint lithography

    2011, Microelectronic Engineering
    Citation Excerpt :

    The grating, being an important optical device, can be used in couplers, optical splitters and filters [1–4]. Furthermore, it can be used in bio-chips by combining microchannels and nano-materials [5–9]. In recent years, grating arrays have been developed for use in bio-chips in order to reduce detection time and increase accuracy.

View all citing articles on Scopus
View full text